deferoxamine - CISMeF

Preferred Label : deferoxamine;

MeSH definition : Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.;

MeSH synonym : deferoxamine b; desferroxamine; desferrioxamine b; deferrioxamine b; deferoximine; desferioximine; desferrioxamine;

CISMeF synonym : b, deferoxamine; b, desferrioxamine;

MeSH hyponym : desferrioxamine B mesylate; desferal; Mesylate, Desferrioxamine B; Deferoxamine Mesilate; Mesilate, Deferoxamine; Deferoxamine Mesylate; Mesylate, Deferoxamine; Deferoxamine Methanesulfonate; Methanesulfonate, Deferoxamine;

MeSH CAS label : butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-;

MeSH Related Number : 70-51-9 (Deferoxamine); desferrioxamine B mesylate; V9TKO7EO6K;

Registry Number MeSH : 70-51-9;

Related CAS MeSH : V9TKO7EO6K (Desferrioxamine B mesylate);

Wikipedia link : https://en.wikipedia.org/wiki/Deferoxamine;

Codes EINECS : 200-738-5;

Is substance : O;

UNII : J06Y7MXW4D;

InChIKey : UBQYURCVBFRUQT-UHFFFAOYSA-N;

Details

Origin ID

D003676;

UMLS CUI

C0011145;

ATC code(s)
- deferoxamine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Deferoxamine [LOINC Challenge]
- Deferoxamine Mesylate [NCIt concept]
- Deferoxamine mesilate (substance) [SNOMED CT concept]
- Deferoxamine mesylate (product) [Inactive SNOMED CT concept]
- Intrathecal Deferoxamine [NCIt concept]
- deferoxamine mesilate [Substance BNPC]
- deferoxamine mesylate [International Nonproprietary Name]
- deferoxamine mesylate [SNOMED Notion]
CISMeF manual mappings
- deferoxamine [Substance BNPC]
Pharmacological action(s)
- siderophores [MeSH Descriptor]
Record concept(s)
- deferoxamine [MeSH concept]
- desferal [MeSH concept]
- desferrioxamine B mesylate [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4-isothiocyanatobenzyl-desferrioxamine [MeSH Supplementary Concept]
- 40SD02 [MeSH Supplementary Concept]
- 7-nitrobenz-2-oxa-1,3-diazole desferrioxamine B [MeSH Supplementary Concept]
- D-CECaT regimen [MeSH Supplementary Concept]
- DfoA protein, erwinia amylovora [MeSH Supplementary Concept]
- N-acetyldeferrioxamine B [MeSH Supplementary Concept]
- N-hydroxydesferrioxamine B [MeSH Supplementary Concept]
- N-methylanthranilic-desferrioxamine [MeSH Supplementary Concept]
- N-methyldeferrioxamine B [MeSH Supplementary Concept]
- N-stearoyldesferrioxamine [MeSH Supplementary Concept]
- N-succinyldesferrioxamine B [MeSH Supplementary Concept]
- aluminoxamine [MeSH Supplementary Concept]
- cobalt-desferal conjugate [MeSH Supplementary Concept]
- copper-desferal complex [MeSH Supplementary Concept]
- deferoxamine G1 [MeSH Supplementary Concept]
- deferoxamine-gamma-folate conjugate [MeSH Supplementary Concept]
- deferoxamineacetyl-cysteinylbiotin [MeSH Supplementary Concept]
- desferrioxamine B-succinyl-phenylalanine(1)-octreotide [MeSH Supplementary Concept]
- desferrioxamine-human serum albumin conjugate [MeSH Supplementary Concept]
- dextran-deferoxamine [MeSH Supplementary Concept]
- ferric-N-(3-phenylglutaryl)desferrioxamine B [MeSH Supplementary Concept]
- ferrioxamine B [MeSH Supplementary Concept]
- gallium(67)-deferoxamine-dialdehyde starch-fibrinogen conjugate [MeSH Supplementary Concept]
- hydroxyethyl starch-deferoxamine conjugate [MeSH Supplementary Concept]
- hydroxyethylstarch-deferoxamine [MeSH Supplementary Concept]
- mangan-desferrioxamin [MeSH Supplementary Concept]
- manganese desferioxamine [MeSH Supplementary Concept]
- nicoyamycin A [MeSH Supplementary Concept]
- polyethylene glycol ferrioxamine [MeSH Supplementary Concept]
- starch deferoxamine [MeSH Supplementary Concept]
- zinc-desferrioxamine [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Deferoxamine mesylate (product) [Inactive SNOMED CT concept]
- Product containing deferoxamine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Deferoxamine [ICD-11 Extension code]
- Deferoxamine [LOINC Challenge]
- Deferoxamine [NCIt concept]
- Deferoxamine (substance) [SNOMED CT concept]
- Product containing deferoxamine (medicinal product) [SNOMED CT concept]
- deferoxamine [ATC Code]
- deferoxamine [Substance BNPC]
- deferoxamine [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients